# Typewriter Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/typewriter-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.typewritertx.com
- Total disclosed funding: $56M
- Latest round: Series A (Sep 2, 2026)
- Investors on record: 5

## About

Founded in 2025 and based in Massachusetts, US, Typewriter Therapeutics, Inc. operates as a biotechnology company that provides RNA-based genetic medicines and gene insertion platforms for cancer, autoimmune, and rare genetic diseases.

## Funding rounds

- Series A, Sep 2, 2026, $56M — SBI Investment, RA Capital Management, ANRI, AN Ventures, Gemseki Investment

## Investors

- SBI Investment (https://capitalatlas.ai/funds/sbi-investment) — Series A
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series A
- ANRI (https://capitalatlas.ai/funds/anri) — Series A
- AN Ventures (https://capitalatlas.ai/funds/an-ventures) — Series A
- Gemseki Investment (https://capitalatlas.ai/funds/gemseki-investment) — Series A